Abstract
Purpose
Estimation of HPV-related disease burden lies at the core of effective disease management. HPV testing is heavily reliant on its retrospective detection in archival clinical cancer samples, especially in parts of the world where HPV screening is not routinely practiced. During the last decade, valuable insights were gained through regional reports based on occasional screening of cervical smears or biopsy sections for the presence of high-risk HPV. HPV 16 and 18 were found to be predominant high-risk HPV subtypes with some regional differences and incidences of co-infections, detected mostly through PCR-based methods. In cases of multiple infections, the presence of viral DNA may not signify its etiologic involvement. The current study, therefore, combines PCR-based detection method with the immunohistochemical (IHC) detection of early viral protein E6 expression, in order to obtain a reliable read out for the disease causing viral subtype, especially in cases of co-infections with oncogenic subtypes other than HPV 16 and 18. Immunohistochemistry (IHC) and PCR-based methods are routinely used laboratory techniques in local hospitals. The concordance between IHC and PCR-based analyses may be useful for determining effective method for the retrospective testing of HPV 16 and 18 disease-related burden.
Methods
A total of 49 paraffin-embedded cervical cancer biopsy sections representing patients from the northwest region of the country were collected from the tertiary care hospital for this study. Genotyping for HPV 16 and 18 was carried out through PCR. The HPV 16/18 E6 protein expression was evaluated by IHC and was compared with the clinicopathological features of cervical cancer.
Results
Molecular analysis of 33 (67 %), E6-expressing paraffin-embedded cervical cancer biopsy sections revealed the presence of HPV 16 (n = 23; 47 %), HPV 18 (n = 6; 12 %) and co-infection (n = 4; 8 %) in 49 tumors through PCR. Despite the PCR-based detection of viral DNA in 37 cervical cancer samples, IHC analysis of E6 expression revealed the etiological involvement of HPV 16/18 in 33 out of 37 cervical cancer samples. Overall, there was 85 % concordance in the results of the two techniques.
Conclusion
IHC analysis provides more conclusive evidence regarding the etiological involvement of the viral subtypes, especially in the presence of multiple infections. About two-thirds (67 %) of cervical cancer samples were found to be caused due to HPV 16/18. Latent occurrence of HPV 16 and 18 is suggested in less than 10 % cervical cancer samples which were found to harbor viral DNA without E6 expression. Furthermore, E6 expression was found to be significantly correlated with the tumor grade.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Abdullah A et al (2016) Molecular diagnosis and phylogenetic analysis of human papillomavirus type-16 from suspected patients in Pakistan. Infect Agents Cancer 11:1. doi:10.1186/s13027-016-0047-z
Baay MF et al (1996) Comprehensive study of several general and type-specific primer pairs for detection of human papillomavirus DNA by PCR in paraffin-embedded cervical carcinomas. J Clin Microbiol 34:745–747
Bosch FX, Lorincz A, Munoz N, Meijer CJ, Shah KV (2002) The causal relation between human papillomavirus and cervical cancer. J Clin Pathol 55:244–265
Burd EM (2003) Human papillomavirus and cervical cancer. Clin Microbiol Rev 16:1–17
Canadas MP, Bosch FX, Junquera ML, Ejarque M, Font R, Ordonez E, de Sanjose S (2004) Concordance of prevalence of human papillomavirus DNA in anogenital and oral infections in a high-risk population. J Clin Microbiol 42:1330–1332
Chan SY, Delius H, Halpern AL, Bernard HU (1995) Analysis of genomic sequences of 95 papillomavirus types: uniting typing, phylogeny, and taxonomy. J Virol 69:3074–3083
Clifford GM, Smith JS, Plummer M, Munoz N, Franceschi S (2003) Human papillomavirus types in invasive cervical cancer worldwide: a meta-analysis. Br J Cancer 88:63–73. doi:10.1038/sj.bjc.6600688
de Boer MA, Jordanova ES, Kenter GG, Peters AA, Corver WE, Trimbos JB, Fleuren GJ (2007) High human papillomavirus oncogene mRNA expression and not viral DNA load is associated with poor prognosis in cervical cancer patients. Clin Cancer Res 13:132–138. doi:10.1158/1078-0432.CCR-06-1568
de Roda Husman AM, Walboomers JM, van den Brule AJ, Meijer CJ, Snijders PJ (1995) The use of general primers GP5 and GP6 elongated at their 3′ ends with adjacent highly conserved sequences improves human papillomavirus detection by PCR. J Gen Virol 76(Pt 4):1057–1062. doi:10.1099/0022-1317-76-4-1057
Dempsey AF (2008) Human papillomavirus: the usefulness of risk factors in determining who should get vaccinated. Rev Obstet Gynecol 1:122–128
Duvlis S, Popovska-Jankovic K, Arsova ZS, Memeti S, Popeska Z, Plaseska-Karanfilska D (2015) HPV E6/E7 mRNA versus HPV DNA biomarker in cervical cancer screening of a group of Macedonian women. J Med Virol 87:1578–1586. doi:10.1002/jmv.24199
Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M, Parkin DM, Forman D, Bray F (2015) Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer 136(5):E359–E386. doi:10.1002/ijc.29210
Griep AE, Herber R, Jeon S, Lohse JK, Dubielzig RR, Lambert PF (1993) Tumorigenicity by human papillomavirus type 16 E6 and E7 in transgenic mice correlates with alterations in epithelial cell growth and differentiation. J Virol 67:1373–1384
Gul S, Murad S, Javed A (2015) Prevalence of high risk human papillomavirus in cervical dysplasia and cancer samples from twin cities in Pakistan. Int J Infect Dis 34:14–19. doi:10.1016/j.ijid.2015.02.018
Higgins GD, Uzelin DM, Phillips GE, McEvoy P, Marin R, Burrell CJ (1992) Transcription patterns of human papillomavirus type 16 in genital intraepithelial neoplasia: evidence for promoter usage within the E7 open reading frame during epithelial differentiation. J Gen Virol 73(Pt 8):2047–2057. doi:10.1099/0022-1317-73-8-2047
Khan S et al (2007) Human papillomavirus subtype 16 is common in Pakistani women with cervical carcinoma. Int J Infect Dis 11:313–317. doi:10.1016/j.ijid.2006.06.007
Lin HP, Huang YY, Wu HY, Kao JT (2004) Method for testing for human papillomavirus infection in patients with cervical intraepithelial disease. J Clin Microbiol 42:366–368
Lin HP, Wang YP, Chiang CP (2011) Expression of p53, MDM2, p21, heat shock protein 70, and HPV 16/18 E6 proteins in oral verrucous carcinoma and oral verrucous hyperplasia. Head Neck 33:334–340. doi:10.1002/hed.21452
Longworth MS, Laimins LA (2004) Pathogenesis of human papillomaviruses in differentiating epithelia. Microbiol Mol Biol Rev 68:362–372. doi:10.1128/MMBR.68.2.362-372.2004
Magaldi TG, Almstead LL, Bellone S, Prevatt EG, Santin AD, DiMaio D (2012) Primary human cervical carcinoma cells require human papillomavirus E6 and E7 expression for ongoing proliferation. Virology 422:114–124. doi:10.1016/j.virol.2011.10.012
Morrison MA, Morreale RJ, Akunuru S, Kofron M, Zheng Y, Wells SI (2011) Targeting the human papillomavirus E6 and E7 oncogenes through expression of the bovine papillomavirus type 1 E2 protein stimulates cellular motility. J Virol 85:10487–10498. doi:10.1128/JVI.05126-11
Moscicki AB, Schiffman M, Kjaer S, Villa LL (2006) Chapter 5: updating the natural history of HPV and anogenital cancer. Vaccine 24 Suppl 3:S3/42–S3/51 (S3-44). doi:10.1016/j.vaccine.2006.06.018
Munoz N et al (2004) Against which human papillomavirus types shall we vaccinate and screen? The international perspective. Int J Cancer 111:278–285. doi:10.1002/ijc.20244
Nakagawa M, Greenfield W, Moerman-Herzog A, Coleman HN (2015) Cross-reactivity, epitope spreading, and de novo immune stimulation are possible mechanisms of cross-protection of nonvaccine human papillomavirus (HPV) types in recipients of HPV therapeutic vaccines. Clin Vaccine Immunol 22:679–687. doi:10.1128/CVI.00149-15
Pisani P, Parkin DM, Bray F, Ferlay J (1999) Estimates of the worldwide mortality from 25 cancers in 1990. Int J Cancer 83:18–29. doi:10.1002/(SICI)1097-0215(19990924)83:1<18:AID-IJC5>3.0.CO;2-M
Roncaglia MT et al (2013) Characterization of p16 and E6 HPV-related proteins in uterine cervix high-grade lesions of patients treated by conization with large loop excision. Oncol Lett 6:63–68. doi:10.3892/ol.2013.1356
Saiki RK et al (1988) Primer-directed enzymatic amplification of DNA with a thermostable DNA polymerase. Science 239:487–491
Schmitt M, Depuydt C, Benoy I, Bogers J, Antoine J, Arbyn M, Pawlita M (2013) Multiple human papillomavirus infections with high viral loads are associated with cervical lesions but do not differentiate grades of cervical abnormalities. J Clin Microbiol 51:1458–1464. doi:10.1128/JCM.00087-13
Shin HJ, Joo J, Yoon JH, Yoo CW, Kim JY (2014) Physical status of human papillomavirus integration in cervical cancer is associated with treatment outcome of the patients treated with radiotherapy. PLoS ONE 9:e78995. doi:10.1371/journal.pone.0078995
Siddiqa A, Zainab M, Qadri I, Bhatti MF, Parish JL (2014) Prevalence and genotyping of high risk human papillomavirus in cervical cancer samples from Punjab. Pak Virus 6:2762–2777. doi:10.3390/v6072762
Tagle DK et al (2014) Expression of E6, p53 and p21 proteins and physical state of HPV16 in cervical cytologies with and without low grade lesions. Int J Clin Exp Med 7:186–193
Takubo K et al (2005) Detection of human papillomavirus infection of the cervix in very elderly women using PCR. Clin Cancer Res 11:2919–2923. doi:10.1158/1078-0432.CCR-04-2367
Walboomers JM et al (1999) Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 189:12–19. doi:10.1002/(SICI)1096-9896(199909)189:1<12:AID-PATH431>3.0.CO;2-F
Watson RA (2005) Human papillomavirus: confronting the epidemic-a urologist’s perspective. Rev Urol 7:135–144
White AE, Livanos EM, Tlsty TD (1994) Differential disruption of genomic integrity and cell cycle regulation in normal human fibroblasts by the HPV oncoproteins. Genes Dev 8:666–677
Williams VM, Filippova M, Soto U, Duerksen-Hughes PJ (2011) HPV-DNA integration and carcinogenesis: putative roles for inflammation and oxidative stress. Future Virol 6:45–57. doi:10.2217/fvl.10.73
Yousuf S, Syed S, Moazzam A, Lucky MH (2010) Frequency of high risk human papillomavirus types in squamous cell carcinoma of cervix among women. J Pak Med Assoc 60:193–196. http://jpma.org.pk/full_article_text.php?article_id=1951
Yutsudo M, Okamoto Y, Hakura A (1988) Functional dissociation of transforming genes of human papillomavirus type 16. Virology 166:594–597
Zur Hausen H (1996) Papillomavirus infections—a major cause of human cancers. Biochim Biophys Acta 1288:F55–F78
Zur Hausen H (2009) Papillomaviruses in the causation of human cancers—a brief historical account. Virology 384:260–265. doi:10.1016/j.virol.2008.11.046
Acknowledgments
We are obliged to the Higher Education Commission of Pakistan and the recurring budget of ASAB provided by NUST for the financial support of this project.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
No conflict of interest is declared by the authors.
Ethical approval
This article does not contain any studies with human participants or animals performed by any of the authors.
Rights and permissions
About this article
Cite this article
Ilahi, N.E., Hashmi, S.N., Anwar, S. et al. Retrospective analysis of HPV 16/18-related disease burden using archival clinical samples. J Cancer Res Clin Oncol 142, 2367–2373 (2016). https://doi.org/10.1007/s00432-016-2227-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00432-016-2227-z